Barreto-Chaves MLM - Search Results

1

S100A8/MYD88/NF-қB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone.

Takano APC, Munhoz CD, Moriscot AS, Gupta S, Barreto-Chaves MLM. Takano APC, et al. J Mol Med (Berl). 2017 Jun;95(6):671-682. doi: 10.1007/s00109-017-1511-y. Epub 2017 Feb 4. J Mol Med (Berl). 2017. PMID: 28161820

2

Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.

Diniz GP, Carneiro-Ramos MS, Barreto-Chaves ML. Diniz GP, et al. Basic Res Cardiol. 2009 Nov;104(6):653-67. doi: 10.1007/s00395-009-0043-1. Epub 2009 Jul 9. Basic Res Cardiol. 2009. PMID: 19588183

3

New insight into the mechanisms associated with the rapid effect of T₃ on AT1R expression.

Diniz GP, Takano AP, Bruneto E, Silva FG, Nunes MT, Barreto-Chaves ML. Diniz GP, et al. J Mol Endocrinol. 2012 May 30;49(1):11-20. doi: 10.1530/JME-11-0141. Print 2012 Aug. J Mol Endocrinol. 2012. PMID: 22525353

4

MiRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy - role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/α-MHC modulation.

Diniz GP, Takano AP, Barreto-Chaves ML. Diniz GP, et al. Mol Cell Endocrinol. 2013 Jul 15;374(1-2):117-24. doi: 10.1016/j.mce.2013.04.010. Epub 2013 Apr 26. Mol Cell Endocrinol. 2013. PMID: 23623871

5

AMPK signaling pathway is rapidly activated by T3 and regulates the cardiomyocyte growth.

Takano AP, Diniz GP, Barreto-Chaves ML. Takano AP, et al. Mol Cell Endocrinol. 2013 Aug 25;376(1-2):43-50. doi: 10.1016/j.mce.2013.05.024. Epub 2013 Jun 6. Mol Cell Endocrinol. 2013. PMID: 23748029

6

Cardiac microRNA-133 is down-regulated in thyroid hormone-mediated cardiac hypertrophy partially via Type 1 Angiotensin II receptor.

Diniz GP, Lino CA, Guedes EC, Moreira Ldo N, Barreto-Chaves ML. Diniz GP, et al. Basic Res Cardiol. 2015 Sep;110(5):49. doi: 10.1007/s00395-015-0504-7. Epub 2015 Jul 23. Basic Res Cardiol. 2015. PMID: 26202011

7

MicroRNA-1 overexpression blunts cardiomyocyte hypertrophy elicited by thyroid hormone.

Diniz GP, Lino CA, Moreno CR, Senger N, Barreto-Chaves MLM. Diniz GP, et al. J Cell Physiol. 2017 Dec;232(12):3360-3368. doi: 10.1002/jcp.25781. Epub 2017 Mar 28. J Cell Physiol. 2017. PMID: 28063219

8

AT1 receptor blockage impairs NF-κB activation mediated by thyroid hormone in cardiomyocytes.

Takano APC, Senger N, Munhoz CD, Barreto-Chaves MLM. Takano APC, et al. Pflugers Arch. 2018 Mar;470(3):549-558. doi: 10.1007/s00424-017-2088-6. Epub 2017 Nov 25. Pflugers Arch. 2018. PMID: 29178049

9

Beta-arrestin 2 mediates cardiac hypertrophy induced by thyroid hormones via AT1R.

Lino CA, de Bortoli Teixeira L, Capelupe Simões S, de Oliveira Silva T, Diniz GP, da Costa-Neto CM, Barreto-Chaves MLM. Lino CA, et al. Among authors: barreto chaves mlm. J Cell Physiol. 2021 Jun;236(6):4640-4654. doi: 10.1002/jcp.30187. Epub 2020 Dec 20. J Cell Physiol. 2021. PMID: 33345322

10

Myocardial ultrastructure in cardiac hypertrophy induced by thyroid hormone--an acute study in rats.

Hu LW, Liberti EA, Barreto-Chaves ML. Hu LW, et al. Virchows Arch. 2005 Mar;446(3):265-9. doi: 10.1007/s00428-004-1175-1. Epub 2005 Jan 25. Virchows Arch. 2005. PMID: 15668802

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters